Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Marrero, Louisiana Clinical Trials

A listing of Marrero, Louisiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis

Sponsor Name (PI): Carole Bitar, MD Sub-PI: Erin Boh, MD, PhD; Brittany Stumpf, MD; Collaborator: Nakhle Saba, MD # of Participants Sites: 1, Tulane University 4: Participant Countries: United States II. PRODUCT INFORMATION Study Title: A phase 2, open label single arm study for evaluating safety & efficacy of apremilast ...

Phase

4.48 miles

Learn More »

Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension

The outcome of liver transplantation (LT) in the presence of moderate to severe POPH is significantly poor with a 50% reported mortality rate in LT recipients having a mean pulmonary artery pressure (mPAP) >35 mmHg and 100% when the mPAP is greater than 50 mmHg; therefore, making moderate to severe ...

Phase

5.49 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).

Phase

7.46 miles

Learn More »

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

This is a Phase 2, randomized, active-controlled, open-label study with a 3-arm parallel design. Healthy 2-month old infants (42 to 98 days of age) with no history of pneumococcal vaccination will be randomized in a 1:1:1 ratio to receive a 4-dose series of: multivalent pneumococcal conjugate vaccine coadministered with Prevnar ...

Phase

9.56 miles

Learn More »

A Study of MTIG7192A in Combination With Atezolizumab in Chemotherapy-Na ve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study will evaluate the safety and efficacy of MTIG7192A plus Atezolizumab compared with placebo plus atezolizumab in chemotherapy-naive patients with locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC), excluding patients with a sensitizing EGFR mutation or ALK translocation.

Phase

9.56 miles

Learn More »